These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 27104757)

  • 1. c-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines.
    Gravina GL; Festuccia C; Popov VM; Di Rocco A; Colapietro A; Sanità P; Monache SD; Musio D; De Felice F; Di Cesare E; Tombolini V; Marampon F
    Radiat Res; 2016 Apr; 185(4):411-22. PubMed ID: 27104757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
    Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
    Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype.
    Rossetti A; Petragnano F; Milazzo L; Vulcano F; Macioce G; Codenotti S; Cassandri M; Pomella S; Cicchetti F; Fasciani I; Antinozzi C; Di Luigi L; Festuccia C; De Felice F; Vergine M; Fanzani A; Rota R; Maggio R; Polimeni A; Tombolini V; Gravina GL; Marampon F
    Int J Radiat Biol; 2021; 97(7):943-957. PubMed ID: 33979259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization.
    Petragnano F; Pietrantoni I; Camero S; Codenotti S; Milazzo L; Vulcano F; Macioce G; Giordani I; Tini P; Cheleschi S; Gravina GL; Festuccia C; Rossetti A; Delle Monache S; Ordinelli A; Ciccarelli C; Mauro A; Barbara B; Antinozzi C; Schiavetti A; Maggio R; Di Luigi L; Polimeni A; Marchese C; Tombolini V; Fanzani A; Bernabò N; Megiorni F; Marampon F
    J Biomed Sci; 2020 Aug; 27(1):90. PubMed ID: 32854690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staufen1 controls mitochondrial metabolism via HIF2α in embryonal rhabdomyosarcoma and promotes tumorigenesis.
    Almasi S; SarmastiEmami S; Baird S; Ning Z; Figeys D; Côté J; Cowan KN; Jasmin BJ
    Cell Mol Life Sci; 2023 Oct; 80(11):328. PubMed ID: 37847286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Myc regulates PD-L1 expression in esophageal squamous cell carcinoma.
    Liang MQ; Yu FQ; Chen C
    Am J Transl Res; 2020; 12(2):379-388. PubMed ID: 32194890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines.
    Giannattasio S; Megiorni F; Di Nisio V; Del Fattore A; Fontanella R; Camero S; Antinozzi C; Festuccia C; Gravina GL; Cecconi S; Dominici C; Di Luigi L; Ciccarelli C; De Cesaris P; Riccioli A; Zani BM; Lenzi A; Pestell RG; Filippini A; Crescioli C; Tombolini V; Marampon F
    J Endocrinol Invest; 2019 Feb; 42(2):183-197. PubMed ID: 29790086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling MYC's Role in Orchestrating Tumor Intrinsic and Tumor Microenvironment Interactions Driving Tumorigenesis and Drug Resistance.
    Doha ZO; Sears RC
    Pathophysiology; 2023 Sep; 30(3):400-419. PubMed ID: 37755397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining.
    Zhan X; Liu Y; Jannu AJ; Huang S; Ye B; Wei W; Pandya PH; Ye X; Pollok KE; Renbarger JL; Huang K; Zhang J
    Front Oncol; 2023; 13():1080989. PubMed ID: 36793601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The botanical drug PBI-05204, a supercritical CO
    Vaccaro S; Rossetti A; Porrazzo A; Camero S; Cassandri M; Pomella S; Tomaciello M; Macioce G; Pedini F; Barillari G; Marchese C; Rota R; Cenci G; Tombolini M; Newman RA; Yang P; Codenotti S; Fanzani A; Megiorni F; Festuccia C; Minniti G; Gravina GL; Vulcano F; Milazzo L; Marampon F
    Front Pharmacol; 2022; 13():1071176. PubMed ID: 36532747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma.
    Pomella S; Porrazzo A; Cassandri M; Camero S; Codenotti S; Milazzo L; Vulcano F; Barillari G; Cenci G; Marchese C; Fanzani A; Megiorni F; Rota R; Marampon F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioresistance in rhabdomyosarcomas: Much more than a question of dose.
    Camero S; Cassandri M; Pomella S; Milazzo L; Vulcano F; Porrazzo A; Barillari G; Marchese C; Codenotti S; Tomaciello M; Rota R; Fanzani A; Megiorni F; Marampon F
    Front Oncol; 2022; 12():1016894. PubMed ID: 36248991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation Response of Human Leukemia/Lymphoma Cells was Improved by 7-Geranyloxycoumarin.
    Bagheri R; Rassouli FB; Gholamhosseinian H; Ebrahimi K; Mahdavi S; Goudarzi S; Iranshahi M; Rafatpanah H; Keramati MR
    Dose Response; 2022; 20(3):15593258221124479. PubMed ID: 36158737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-sarcoma characterization of lncRNAs in the crosstalk of EMT and tumour immunity identifies distinct clinical outcomes and potential implications for immunotherapy.
    Shi D; Mu S; Pu F; Zhong B; Hu B; Muhtar M; Tong W; Shao Z; Zhang Z; Liu J
    Cell Mol Life Sci; 2022 Jul; 79(8):427. PubMed ID: 35842562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microRNA-4723-5p regulated by c-myc in triple-negative breast cancer.
    Jin XX; Gao C; Wei WX; Jiao C; Li L; Ma BL; Dong C
    Bioengineered; 2022 Apr; 13(4):9097-9105. PubMed ID: 35382692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem Cell Characteristics and Therapy Resistance in Ovarian Cancer Cells.
    Löblein MT; Falke I; Eich HT; Greve B; Götte M; Troschel FM
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas.
    Parekh U; McDonald D; Dailamy A; Wu Y; Cordes T; Zhang K; Tipps A; Metallo C; Mali P
    iScience; 2021 Oct; 24(10):103149. PubMed ID: 34646987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.
    Cassandri M; Pomella S; Rossetti A; Petragnano F; Milazzo L; Vulcano F; Camero S; Codenotti S; Cicchetti F; Maggio R; Festuccia C; Gravina GL; Fanzani A; Megiorni F; Catanoso M; Marchese C; Tombolini V; Locatelli F; Rota R; Marampon F
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Radiobiology of Vestibular Schwannomas to Overcome Radiation Resistance.
    Thielhelm TP; Goncalves S; Welford SM; Mellon EA; Cohen ER; Nourbakhsh A; Fernandez-Valle C; Telischi F; Ivan ME; Dinh CT
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of MicroRNA Related to Irradiation Response and the Regulation Mechanism of miRNA-96-5p in Rectal Cancer Cells.
    Wu F; Wu B; Zhang X; Yang C; Zhou C; Ren S; Wang J; Yang Y; Wang G
    Front Oncol; 2021; 11():699475. PubMed ID: 34458143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.